Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women

CONTEXT: The ideal therapy for endometriosis (EM) and uterine fibroids (UFs) would suppress estrogenic drive to the endometrium and myometrium, while minimizing vasomotor symptoms and bone loss associated with current treatments. An integrated neurokinin-kisspeptin system involving substance P and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawsey, Steve, Mills, Edouard Gregory, Ballantyne, Elizabeth, Donaldson, Kirsteen, Kerr, Mary, Trower, Mike, Dhillo, Waljit Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277204/
https://www.ncbi.nlm.nih.gov/pubmed/33624806
http://dx.doi.org/10.1210/clinem/dgab108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277204/
https://www.ncbi.nlm.nih.gov/pubmed/33624806
http://dx.doi.org/10.1210/clinem/dgab108

Ejemplares similares